A study published in Cancer found that many young cancer survivors are grappling with financial woes and a small percentage have had to file for bankruptcy.
Drug manufactueres have announced a 60 percent reduction in the U.S. prices of their cholesterol-lowering medication, Praluent (alirocumab).
The United States continues to spend more per capita on health care than any other developed country — not for better medical care, because of higher prices.
The development of newer medications does increase drug prices overall but a study suggests drug manufacturers hike the prices of older medicines too.
The Endocrine Society issued a statement imploring manufacturers, pharmacies, insurers, and others to lower out-of-pocket expenses for insulin.
Diabetes care falls between primary care physicians and endocrinologists. Will we need more specialists as diabetes becomes more common?
More than half of Americans surveyed report they’ve been surprised by an unexpected medical bill they believed would be covered by their health insurance.
When you first start insulin treatment for diabetes, you have more questions than answers. Here's what you should know to get started.
After ten post-surgery recoveries using opioids, Grant Hill tried a non-opioid approach the eleventh time around.
Melatonin is commonly used as a sleep aid but its supplement status poses some safety issues. Here’s the low down on melatonin.